Big Biotech Biogen is venturing into the city, paying $16 million in cash to partner up with an RNAi company to build ...

Biogen and City Therapeutics are collaborating to develop select RNAi therapies in a $46 million partnership. City Therapeutics, a private biopharmaceutical company, will offer its RNAi-engineering ...

A start-up that launched only 8 months ago has attracted the attention of Biogen, a major developer of neurological drugs.

Biotech major Biogen (Nasdaq: BIIB) and fellow Cambridge, USA-based City Therapeutics, today announced a strategic collaboration to develop select novel RNA interference (RNAi)-based therapies.

Bio­gen is div­ing in­to the RNAi field with City Ther­a­peu­tics, a biotech led by sev­er­al for­mer Al­ny­lam lead­ers.

May 21, 2025 • We asked some of our trusted critics which upcoming books they are most looking forward to. Here are the fiction and nonfiction titles they picked. November 25, 2024 • Books We ...

The COVID-19 pandemic showed the value of changing direction in research. It should be incentivized, encouraged and celebrated. An analysis of landscape features and of river deposits preserved in ...

There is no English content under this tag.

No need to dread a book report! When kids find titles that are engaging, interesting, and thought-provoking, they're hooked. If it's fiction, students can dissect plot, theme, and characters. If it's ...

Fifth‐generation (5G) communications integrate the role of unmanned aerial vehicles (UAVs) to achieve certain objectives. Interference among 5G users can be a serious problem for which a simple but ...